Table 2.
Virus | Screen Type | gRNA Library | Cells | Top Screening Hits | Ref. |
---|---|---|---|---|---|
HIV | CRISPR-ko | Custom library of 187,536 gRNAs targeting 18,543 genes | GXR cell line | TPST2, SLC35B2, ALCAM, CCR5, CD4 | [34] |
CRISPRi | CRISPRi-v2 | Jurkat | TMEM178A, FTSJ3, INTS2, INTS5, INTS8, NICN1 | [88] | |
CRISPR-ko | GeCKO | C11 cell line | PEPB1, BRD2, BRD4 | [89] | |
CRISPR-ko | GeCKO | Jurkat | ZNF304 | [90] | |
CRISPR-ko | GeCKO v2 | Jurkat (J-Lat 10.6 cell line) | 52 genes including IWS1, POLE3, POLR1B, PSMD1, TGM2 | [91] | |
CRISPR-ko | GeCKO v2 | Jurkat (HIV-1 latent infection cell line [C11]) | TCS1, DEPDC5, SUV39H1, SPATA6L, NFKB2, and other genes | [92] | |
Coronaviruses (SARS-CoV-2, MERS) |
CRISPR-ko | Brunello | Huh-7.5 | 146 (37 °C) and 171 (33 °C) genes, including TMEM41B for all of investigated viruses | [93] |
CRISPR-ko | Custom library of 83,963 gRNAs | Vero-E6 | Genes of SWI/SNF complex, ACE2, DPP4, CTSL, PCBD1, KMT2D, SMAD3, HMGB1, and others | [94] | |
CRISPR-ko | GeCKO v2 | A549ACE2 | RAB7A, CCDC22, VPS35, ACE2, CTSL, and others | [95] | |
CRISPR-ko | GeCKO v2 | Huh7.5.1 | TMEM106B and other genes | [96] | |
Dengue virus (DENV) |
CRISPR-ko | GeCKO v2 | Haploid HAP1 cells | 17 genes including DPM1 and DPM3 | [97] |
CRISPR-ko | GeCKOv2 | Huh7.5.1 | STT3A, STT3B, DC2, MAGT, RPN2, OST4 | [98] | |
Zika virus (ZIKV), yellow fever virus |
CRISPR-ko | GeCKO | HAP1 | TMEM41B and VMP1 (overlap between the two viruses) | [99] |
ZIKV | CRISPR-ko | Brunello | TS576 | CENPH, ITGB5, MYLPH, HOMER1, BAALC, GABBR2, EPHA10, PTNP2, GCNT7, TRAM1, TMEM41B | [100] |
CRISPRa | LentiSAMv2 | Huh7 | IFI6, IFNL2, ISG20, HELZ2 | [101] | |
CRISPR-ko | LentiCRISPRv1; custom library | Human neural progenitors cells | TM9SF2, ATP6V1C1, ATP6V1F, SSR2, SSR3, EMC2, EMC6, C3orf58, ISG15, SOCS3, STAT3 | [102] | |
Hepatitis A virus (HAV) | CRISPR-ko | Brunello | HeLa | 39 genes including UGCG, GALE, and SLC35A2 | [103] |
Hepatis B virus (HBV) | CRISPR-ko | Custom library of 19,050 genes, with 5 gRNAs/gene | HepG2 | 22 pro-HBsAg genes, including ZCCHC14, NXT1, and ENY2; 38 anti-HBsAg genes, including DCAF7, UBE2J1, RNF139, and UBE2J2 |
[104] |
Epstein-Barr virus | CRISPR-ko | AVANA | P3HR-1 | MYC, EP300, STAGA, FACT, cohesin subunits | [105] |
CRISPR-ko | Brunello | Lymphoblastoid cell lines (LCL) | TAF family proteins, MEF2C | [106] | |
CRISPR-ko | Avana | P3HR-1, GM12878 | 57 genes for P3HR1 and 87 genes for GM12878 | [107] | |
Human cytomegalovirus (HCMV) | CRISPR-ko | GeCKO v2 | ARPE-19; HEL fibroblasts |
OR14I1, PDGFRA | [108] |
CRISPR-ko | GeCKO v2 | Human foreskin fibroblasts (HFF) | PDGFRA | [109] | |
Influenza A virus (IAV) | CRISPR-ko | AVANA-4 | A549 | WDR7, CCDC115, TMEM199, CMTR1 | [110] |
CRISPR-ko | GeCKO | A549 | SLC35A1 and other genes | [111] | |
Adeno-associated virus | CRISPR-ko | GeCKO | Huh7 | GPR108, NEU1, GCNT4, CTSA | [112] |
CRISPR-ko | GeCKO v2 | Huh7 | Crb3, CLDN15 | [113] | |
Ebola virus (EBOV) | CRISPR-ko | GeCKO v2 | Huh7.5.1 | GNPTAB, NPC1, SPNS1, SLC30A1, HOPS complex, UVRAG | [114] |
Enteroviruses (RV-C15 and non-polio EV-D68) | CRISPR-ko | GeCKO v2 | H1-HeLa cells | SETD3, CSDE1, PLA2G16 | [115] |
Severe fever with thrombocytopenia syndrome virus | CRISPR-ko | GeCKO v2 | HeLa | SNX11 | [116] |
Norovirus restriction factors | CRISPRa | Calabrese | Hela | TRIM7, PITX1, HOXC11, DDX60, MX1, PLSCR1 | [117] |
Flaviviruses | CRISPR-ko | Brunello | Huh7.5 | IFI6, STAT2, IRF9 | [118] |
CRISPR-ko | GeCKO v2 | 293T | STT3A, SEC63, SPCS1, SPCS3 | [119] | |
West Nile virus | CRISPR-ko | Custom library of 77,406 gRNAs covering 20,121 genes | 293FT | EMC2, EMC3, SEL1L, DERL2, UBE2G2, UBE2J1, HRD1 | [120] |
Arthritogenic alphaviruses (chikungunya, Ross River, Mayaro, O’nyong nyong) | CRISPR-ko | GeCKO v2 | 3T3 | MXRA8 | [121] |
Rotavirus | CRISPR-ko | GeCKO | H1-Hela | SLC35A1, GNE, CMAS, UGCG, FA2H, LATS2, STAG2 | [122] |